2929 — Pharma Foods International Co Income Statement
0.000.00%
Last trade - 00:00
- ¥30bn
- ¥33bn
- ¥69bn
- 84
- 77
- 39
- 79
2019 July 31st | 2020 July 31st | 2021 July 31st | 2022 July 31st | 2023 July 31st | |
---|---|---|---|---|---|
Period Length: | 12 M | 12 M | 12 M | 12 M | 12 M |
Source: | Yuho | Yuho | Yuho | Yuho | Yuho |
Standards: | JAS | JAS | JAS | JAS | JAS |
Status: | Final | Final | Final | Final | Final |
Revenue | |||||
Total Revenue | 10,533 | 15,353 | 46,752 | 60,185 | 68,572 |
Cost of Revenue | |||||
Gross Profit | 8,537 | 12,175 | 39,725 | 48,108 | 55,279 |
Selling / General / Administrative Expenses | |||||
Research And Development | |||||
Depreciation and Amortization | |||||
Unusual Expense / Income | |||||
Other Operating Expenses | |||||
Total Operating Expenses | 9,957 | 14,554 | 41,080 | 59,023 | 65,004 |
Operating Profit | 576 | 800 | 5,672 | 1,162 | 3,568 |
Gain / Loss on Sale of Assets | |||||
Total Net Non Operating Interest Income / Expense | |||||
Other Net Non Operating Costs | |||||
Net Income Before Taxes | 669 | 849 | 5,765 | 1,423 | 3,542 |
Provision for Income Taxes | |||||
Net Income After Taxes | 508 | 691 | 3,841 | -374 | 3,080 |
Minority Interest | |||||
Net Income Before Extraordinary Items | |||||
Net Income | 500 | 691 | 3,841 | -374 | 3,080 |
Adjustments to Net Income | |||||
Income Available to Common Shareholders Excluding Extraordinary Items | |||||
Income Available to Common Shareholders Including Extraordinary Items | |||||
Diluted Net Income | 500 | 691 | 3,841 | -374 | 3,081 |
Diluted Weighted Average Shares | |||||
Basic EPS Including Extraordinary Items | |||||
Diluted EPS Including Extraordinary Items | |||||
Diluted EPS Excluding Extraordinary Items | |||||
Normalised Income Before Taxes | |||||
Normalised Income After Taxes | |||||
Normalised Income Available to Common Shareholders | |||||
Diluted Normalised EPS | 17.7 | 23.4 | 134 | -14.7 | 111 |
Dividends per Share | |||||
Special Dividends per Share |